Marshall Wace’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$900K Buy
+4,259
New +$782K ﹤0.01% 2250
2024
Q4
Sell
-3,000
Closed -$377K 2865
2024
Q3
$377K Buy
3,000
+900
+43% +$113K ﹤0.01% 2034
2024
Q2
$228K Buy
+2,100
New +$205K ﹤0.01% 2257
2023
Q3
Sell
-5,855
Closed -$362K 2522
2023
Q2
$362K Sell
5,855
-41,690
-88% -$2.47M ﹤0.01% 2087
2023
Q1
$2.76M Buy
+47,545
New +$2.73M 0.01% 1282
2021
Q1
Sell
-15,028
Closed -$998K 2740
2020
Q4
$998K Sell
15,028
-5,234
-26% -$345K 0.01% 1212
2020
Q3
$1.26M Buy
+20,262
New +$1.27M 0.01% 937

Other funds holding NHC

Marshall Wace's NHC Position: Q2 2026 in Review

Marshall Wace opened a new position in National Healthcare (NHC) in Q2 2026: 4,259 shares worth $900K. The stake represents ﹤0.01% of the portfolio and ranks #2250 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NHC as recently as Q3 2024.

Marshall Wace first reported a position in NHC in Q3 2020 and has held it in 7 quarters since. The position peaked at $2.76M in Q1 2023. 248 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Marshall Wace held 4,259 shares of National Healthcare worth $900K as of Q2 2026.
  • National Healthcare was a new Marshall Wace position in Q2 2026.
  • National Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2250 holding.
  • Marshall Wace first reported a position in National Healthcare in Q3 2020 and has held it in 7 quarters since.
  • Marshall Wace's National Healthcare position peaked at $2.76M in Q1 2023.
  • 248 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.